{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:41:53Z","timestamp":1780047713250,"version":"3.53.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020316","name":"OrbusNeich Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01EB028798"],"award-info":[{"award-number":["1R01EB028798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX001729"],"award-info":[{"award-number":["I01BX001729"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.omtn.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T11:52:26Z","timestamp":1659613946000},"page":"577-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Saami K.","family":"Yazdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire V.","family":"Cawthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton","family":"Huett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma H.","family":"Giangrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Francis J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.08.007_bib1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/CIRCOUTCOMES.109.930735","article-title":"Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States","volume":"3","author":"Mahoney","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.omtn.2022.08.007_bib2","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2022.08.007_bib3","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.omtn.2022.08.007_bib4","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2022.08.007_bib5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.omtn.2022.08.007_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.omtn.2022.08.007_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00270-004-0029-1","article-title":"Guidelines for stenting in infrainguinal arterial disease","volume":"27","author":"Tsetis","year":"2004","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.omtn.2022.08.007_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","article-title":"Classification and clinical impact of restenosis after femoropopliteal stenting","volume":"59","author":"Tosaka","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.omtn.2022.08.007_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2022.08.007_bib10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2022.08.007_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.omtn.2022.08.007_bib12","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic Review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.omtn.2022.08.007_bib13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/mt.2015.235","article-title":"Smooth muscle cell-targeted RNA aptamer inhibits neointimal formation","volume":"24","author":"Thiel","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.08.007_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.omtn.2019.03.005","article-title":"Delivery of cell-specific aptamers to the arterial wall with an occlusion perfusion catheter","volume":"16","author":"Udofot","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.08.007_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvir.2019.11.015","article-title":"Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Katsanos","year":"2020","journal-title":"J.\u00a0Vasc. Interv. Radiol."},{"key":"10.1016\/j.omtn.2022.08.007_bib16","doi-asserted-by":"crossref","first-page":"e43836","DOI":"10.1371\/journal.pone.0043836","article-title":"Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection","volume":"7","author":"Thiel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.08.007_bib17","first-page":"1373","article-title":"Preclinical restenosis models and drug-eluting stents: still important, still much to learn","volume":"44","author":"Schwartz","year":"2004","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.omtn.2022.08.007_bib18","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jvir.2009.08.019","article-title":"Paclitaxel-induced arterial wall toxicity and inflammation: part 2--long-term tissue response in a minipig model","volume":"20","author":"Stampfl","year":"2009","journal-title":"J.\u00a0Vasc. Interv. Radiol."},{"key":"10.1016\/j.omtn.2022.08.007_bib19","first-page":"383","article-title":"Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents","volume":"25","author":"Yazdani","year":"2013","journal-title":"J.\u00a0Invasive Cardiol."},{"key":"10.1016\/j.omtn.2022.08.007_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fphar.2018.00808","article-title":"In\u00a0vitro and in\u00a0vivo assessment of Keratose as a novel excipient of paclitaxel coated balloons","volume":"9","author":"Turner","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtn.2022.08.007_bib21","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1038\/s41598-021-98063-z","article-title":"Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease","volume":"11","author":"Atigh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.08.007_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071596","article-title":"Pre-clinical investigation of Keratose as an excipient of drug coated balloons","volume":"25","author":"Goel","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2022.08.007_bib23","first-page":"132","article-title":"Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model","volume":"83","author":"Yazdani","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253122002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:33:05Z","timestamp":1761874385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253122002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":23,"alternative-id":["S2162253122002037"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.08.007","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}